AMETEK Inc. Achieves Record Q2 2026 Results

By Philip Seaworth • Tuesday, August 04 10:54 • Permanent Link

AMETEK posted record second-quarter 2026 results, with sales rising 15% from a year earlier to $2.04 billion.

Earnings per diluted share increased to a record $1.77 on a GAAP basis, while adjusted earnings climbed 17% to a record $2.09 per share from the second quarter of 2025. Operating income reached a record $528.2 million on a GAAP basis, and adjusted operating income rose 18% to a record $544.4 million. Operating margin improved to 26.6%, up 60 basis points from the prior year.

Cash generation strengthened sharply. Operating cash flow increased 35% to $483.7 million, and free cash flow conversion to net income was 111%.

Orders were a standout metric for the quarter, rising 28% for the second consecutive quarter.

By segment, Electronic Instruments Group sales increased 14% to $1.32 billion. Its adjusted operating income rose 12% to $384.7 million, and core margins improved 40 basis points to 30.1%.

Electromechanical Group had the strongest top-line growth, with sales up 17% to a record $723.2 million. Adjusted operating income jumped 32% to a record $190.5 million, and operating margin was 26.3%.

AMETEK also raised full-year guidance. It now expects 2026 sales to increase about 10% versus 2025, compared with the prior outlook for adjusted earnings per share of $7.94 to $8.14. The new range is $8.20 to $8.30, implying 10% to 12% growth over the comparable 2025 basis.

For the third quarter, AMETEK said sales should rise in the high single digits from a year earlier, with adjusted earnings per share of $2.08 to $2.10, up 10% to 11% from the third quarter of 2025. Today the company's shares have moved 1.35% to a price of $247.055. For the full picture, make sure to review AMETEK INC/'s 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.